EARLY SAFETY DATA FROM A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PHASE 2B STUDY OF IGV-001, AN AUTOLOGOUS CELL IMMUNOTHERAPY, VERSUS PLACEBO, IN NEWLY DIAGNOSED GLIOBLASTOMA (NDGBM) J. Bradley Elder , Simon Hanft , Ian Y. Lee , Christopher Farrell , John A. Boockvar , Brad E. Zacharia , Lyndon Kim , Michael Schulder , Carlos Eduardo Silva Correia , Rohan Ramakrishna , Eric T. Wong , Julian Wu , Vijay Agarwal , Nduka Amankulor , Ankush Bhatia , Linton T. Evans , Cameron Brennan , Brian J. Gill , Soma Sengupta , Alfredo Quinones-Hinojosa , Pierre Giglio , Kyle Wu , Synphen H. Wu , Cristina Falo , Tobias Walbert , Adam Robin , Iyad Alnahhas , Morana Vojnic , A. Gabriella Wernicke , Dawit Aregawi , Robert Maurer , Saadi Ghatan , Samuel Singer , Suriya Jeyapalan , Rajiv Magge , Athar N. Malik , Nitesh Patel , Amy Chan , Fabio Iwamoto , Adilia Hormigo , Dominique Higgins , Mahua Dey , Nelson S. Moss , Wendy Sherman , Leila Neese , Gregory K. Pennock , Charles Scott , Raul Perez-Olle , David W. Andrews NEURO-ONCOLOGY（2024）
AI 理解论文
溯源树
样例
